PAPILLOMAVIRAL CARCINOGENESIS. MAJOR ACHIEVEMENTS AND CERTAIN CHALLENGES PART 2. HPV-ASSOCIATED CANCERS IN RUSSIA. PREVENTIVE HPV VACCINES

G M Volgareva

doi:10.17650/1726-9784-2019-19-2-31-38

Abstract

Cervical cancer (CC) incidence rate made up about 5 % in overall women cancer incidence in Russia in 2015. CC morbidity rose by 24.47 %during 2005–2015. Despite the fact that aggregated standardized cancer mortality rates for both men and women during 2005–2015 declined, women CC mortality increased by 8.3 %. CC is the leading cancer mortality cause in women aged 30–39 years. Moreover growth of oraland pharynx cancer incidence rates in both genders as well as penile cancer in men all indicate to an unfavorable trend. The present Reviewpart contains data on HPV-associated cancers in Russia, vertical HPV transition as well as preventive HPV vaccines.

Highlights

Cervical cancer (CC) incidence rate made up about 5 % in overall women cancer incidence in Russia in 2015
CC morbidity rose by 24.47 % during 2005–2015
Growth of oral and pharynx cancer incidence rates in both genders as well as penile cancer in men all indicate to an unfavorable trend

Summary

Introduction

ВПЧ-ассоциированные формы рака в России В структуре онкологической заболеваемости российских женщин на долю РШМ в 2015 г. Рост показателей заболеваемости раком ротовой полости и глотки, а также раком полового члена у мужчин служит, как и в случае с РШМ, проявлением тревожной тенденции и свидетельствует в пользу необходимости профилактики ВПЧ-инфекции в России.

Results

Conclusion